SCHEMBL13633553

SCHEMBL13633553

O=C(Nc1cn2ccc(Br)cc2n1)Oc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
GAA P10253 3/20 0.46
MEN1 O00255 2/20 0.46
METTL3 Q86U44 2/20 0.41
CYP1A2 P05177 2/20 0.40
ALDH1A1 P00352 4/20 0.39
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TRPV1 Q8NER1 2/20 0.39
NPC1 O15118 2/20 0.39
FAAH O00519 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX12 P18054 1/20 0.39
CYP2C19 P33261 1/20 0.39
HTT P42858 1/20 0.38
MAOB P27338 1/20 0.38
RAD51 Q06609 1/20 0.37
KDM4E B2RXH2 2/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2392861 0.83 RAB9A (0.50) CYP1A2ALDH1A1MAPTSMN1; SMN2NPC1
SCHEMBL1302571 0.82 MAP3K5 (0.52) KMT2AGAAMEN1METTL3CYP1A2
SCHEMBL13633518 0.78 KDM4E (0.46) METTL3CYP1A2ALDH1A1SMN1; SMN2NPC1
SCHEMBL13633497 0.74 MAP3K5 (0.40) METTL3CYP1A2ALDH1A1SMN1; SMN2NPC1
SCHEMBL13633508 0.72 METTL3 (0.42) METTL3
SCHEMBL17775010 0.72 KMT2A (0.55) KMT2AGAAMEN1CYP1A2ALDH1A1
SCHEMBL11132897 0.70 KMT2A (0.82) KMT2AGAAMEN1CYP1A2ALDH1A1
SCHEMBL16439325 0.70 KDM4E (0.42) GAAMETTL3ALDH1A1SMN1; SMN2NPC1
SCHEMBL59299 0.69 KMT2A (0.50) KMT2AGAAMEN1CYP1A2ALDH1A1
SCHEMBL7244914 0.69 ALDH1A1 (0.56) KMT2AGAAMEN1CYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 US disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191394-A1 Antibacterial agents MRPL21, RPN2, FBL KMT2A 4819/4885GAA 91/4885MEN1 2732/4885
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS DPYD, TYMP, ITPA KMT2A 4669/4885GAA 351/4885MEN1 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.